Aurinia Pharmaceuticals Inc. Share Price & Technical Analysis
AUPH · $15.22 (-1.49%)
Healthcare / Biotechnology
$15.22
-1.49%
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and p…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-1% return in May, -6% avg return in past 3 year May month.
-6% return in 2026, 50% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -2% | 4% | 3% | -1% | – | – | – | – | – | – | – | -6% |
| 25 | -13% | 1% | 0% | 3% | -5% | 8% | 8% | 28% | -7% | 19% | 23% | -2% | 62% |
| 24 | -16% | -25% | -12% | 2% | 6% | 6% | 4% | 17% | 7% | -1% | 24% | 1% | 12% |
| 23 | 63% | 0% | 20% | 3% | -20% | 9% | 18% | -21% | -14% | -5% | 18% | 5% | 75% |
| 22 | -27% | -27% | 1% | -17% | 10% | -11% | -18% | -9% | 4% | 7% | -39% | -17% | -143% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.05B
P/E ratio
7.38
52W high
$16.88
52W low
$7.29
Volume
9,67,683
Beta
1.45
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Aurinia Pharmaceuticals Inc. share price today?
- Aurinia Pharmaceuticals Inc. (AUPH) last traded around $15.22 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AUPH have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AUPH. Download the app for real-time alerts.
- How can I analyze Aurinia Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.